Table 2: Outcomes in both groups at baseline, week 2 and 12 with group differences as indicators of change.

Integrative medicine groupRheumatology group Mean diff Mean diff (95% CI)
BaselineVisit 2Visit 3BaselineVisit 2Visit 3 1-2 (95% CI) value 1–3 (95% CI) Value

FIQ score −11.2 (−20.1, −2.3)0.014−6.7 (−17.5, 4.1)0.223
Pain score −17.5 (−28.8, −6.1)0.003−13.0 (−28.0, 2.1)0.091
Quality of sleep −15.5 (−30.6, −0.4)0.04416.5 (−30.0, −3.1)0.016
HADS Anxiety −2.9 (−4.6, −1.3)<.001−2.3 (−3.8, −0.9)0.002
HADS Depression −1.5 (−3.3, 0.3)0.097−2.0 (−4.0, −0.0)0.046
SES Pain Perception −10.1 (−14.7, −5.5)<.001−5.2 (−11.0, 0.5)0.075
STAI State Score −8.2 (−13.9, −2.4)0.005−6.1 (−11.8, −0.4)0.036
STAI Trait Score −8.3 (−12.3, −4.2)<.001−4.8 (−8.9, −0.7)0.022
BfS Well-being −6.8 (−12.5, −1.2)0.018−1.4 (−8.0, 5.2)0.675

Values are mean SD if not indicated otherwise. SBP: systolic blood pressure; DBP: diastolic blood pressure.
STAI: State and Trait Anxiety questionnaire, FIQ: Fibromyalgia impact questionnaire; HADS: Hospital Anxiety and Depression scale;
1-2 = difference between groups from baseline to visit 2 at 2 weeks, 1–3 = difference between groups from baseline to visit 3 at 12 weeks,
values for between group difference of change, adjusted.